Abstract
Delirium is a condition of acute and reversible confusion characterized by fluctuation, inattention, disorganized thinking, and an altered level of consciousness. The instrument most commonly used to assess delirium in the acute setting is the confusion assessment method or CAM. The CAM has been validated against geriatric psychiatrists’ ratings using DSM-III-R (Diagnostic and Statistical Manual of Mental Disorders, Third Edition, Revised; American Psychiatric Association [APA] 1987) criteria and has been shown to have sensitivity between 94% and 100% and specificity between 90% and 95% (Inouye et al. 1990). It is based on DSM-III (APA 1980) and DSM-IV (APA 1994) criteria for delirium (Table 1) and assesses four features of delirium:
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Agostini JV, Leo-Summers LS, Inouye SK (2001) Cognitive and other adverse effects of diphenhydramine use in hospitalized older patients. Arch Intern Med 161:2091–2097
Alagiakrishnan K, Wiens CA (2004) An approach to drug induced delirium in the elderly. Postgrad Med J 80:388–393
American Psychiatric Association (1980) Diagnostic and statistical manual of mental disorders, 3rd edn. American Psychiatric Association, Washington, DC
American Psychiatric Association (1987) Diagnostic and statistical manual of mental disorders, 3rd edn. American Psychiatric Association, Washington, DC, rev
American Psychiatric Association (1994) Diagnostic and statistical manual of mental disorders, 4th edn. American Psychiatric Association, Washington, DC
American Psychiatric Association (2000) Diagnostic and statistical manual of mental disorders, 4th edn. American Psychiatric Association, Washington, DC, text revn
Ancelin ML, Carrière I, Helmer C et al (2012) Steroid and nonsteroid anti-inflammatory drugs, cognitive decline, and dementia. Neurobiol Aging 33:2082–2090
Applegate WB, Curb JD (1990) Designing and executing randomized clinical trials involving elderly persons. J Am Geriatr Soc 38:943–950
Boustani M, Hall KS, Lane KA et al (2007) The association between cognition and histamine-2 receptor antagonists in African Americans. J Am Geriatr Soc 55:1248–1253
Brodeur MR, Stirling AL (2001) Delirium associated with zolpidem. Ann Pharmacother 35:1562–1564
Cassell CK, Leipzig RM, Cohen HJ et al (2003) Geriatric medicine: an evidence-base approach, 4th edn. Springer, New York
Clegg A, Young JB (2011) Which medications to avoid in people at risk of delirium: a systematic review. Age Ageing 40:23–29
Cook I (2004) Guideline Watch: Practice Guideline for the Treatment of Patients with Delirium, American Psychiatric Association. Psychiatry online 1–4. Acessed June 30, 2012
Devanand DP, Schultz SK (2011) Consequences of antipsychotic medications for the dementia patient. Am J Psychiatry 168:767–769
Fick D, Kolanowski A, Waller J (2007) High prevalence of central nervous system medications in community–dwelling older adults with dementia over a three year period. Aging Ment Health 11(5):588–595
Fick DM, Agostini JV, Inouye SK (2002) Delirium superimposed on dementia: a systematic review. J Am Geriatr Soc 50:1723–1732
Finkle WD, Der JS, Greenland S et al (2011) Risk of fractures requiring hospitalization after an initial prescription for zolpidem, alprazolam, lorazepam, or diazepam in older adults. J Am Geriatr Soc 59:1883–1890
Flanagan NM, Fick DM (2010) Delirium superimposed on dementia. Assessment and intervention. J Gerontol Nurs 36:19–23
Gaudreau JD, Gagnon P, Harel F, Tremblay A (2005) Psychoactive medications and risk of delirium in hospitalized cancer patients. J Clin Oncol 23:6712–6718
Gill SS, Bronskill SE, Normand SL et al (2006) Antipsychotic drug use and mortality in older adults with dementia. Ann Intern Med 146:775–786
Giron MS, Forsell Y, Bernsten C, Thorslund M, Winblad B, Fastborn J (2001) Psychotropic drug use in elderly people with and without dementia. Int J Geriatr Psychiatry 16:900–906
Han L, McCusker J, Cole M et al (2001) Use of medications with anticholinergic effect predicts clinical severity of delirium symptoms in older medical inpatients. Arch Intern Med 161:1099–1105
Hughes CG, Pandharipande PP (2011) The effects of perioperative and intensive care unit sedation on brain organ dysfunction. Anesth Analg 112:1212–1217
Inouye SK (2006) Delirium in older persons. N Engl J Med 354:1157–1165
Inouye SK, Ferrucci L (2006) Elucidating the pathophysiology of delirium and the interrelationship of delirium and dementia. J Gerontol A Biol Sci Med Sci 61:1277–1280
Inouye SK, van Dyck CH, Alessi CA, Balkin S, Siegal AP, Horwitz RI (1990) Clarifying confusion: the confusion assessment method. A new method for detection of delirium. Ann Intern Med 113:941–948
Kolanowski AM, Fick DM, Clare L, Therrien B, Gill D (2010) An intervention for delirium superimposed on dementia based on cognitive reserve theory. Aging Ment Health 14:232–242
Kolanowski AM, Fick DM, Litaker MS, Clare L, Leslie D, Boustani M (2011) Study protocol for the recreational stimulation for elders as a vehicle to resolve delirium superimposed on dementia (reserve for DSD) trial. Trials 12:119
Kotlyar M, Gray SL, Maher RL, Hanlon JT (2011) Psychiatric manifestations of medications in the elderly. In: Agronin MA, Maletta GJ (eds) Principles and practice of geriatric psychiatry. LWW, Baltimore
Lepousé C, Lautner CA, Liu L, Gomis P, Leon A (2006) Emergence delirium in adults in the post-anaesthesia care unit. Br J Anaesth 96:747–753
Levin TT, Bakr MH, Nikolova T (2010) Case report: delirium due to a diltiazem-fentanyl CYP3A4 drug interaction. Gen Hosp Psychiatr 32:648
Marcantonio ER, Goldman L, Orav EJ, Cook EF, Lee TH (1998) The association of intraoperative factors with the development of postoperative delirium. Am J Med 105:380–384
Moore AR, O’Keeffe ST (1999) Drug-induced cognitive impairment in the elderly. Drugs Aging 15:15–28
Pandharipande P, Shintani A, Peterson J et al (2006) Lorazepam is an independent risk factor for transitioning to delirium in intensive care unit patients. Anesthesiology 104:21–26
Reid MC, Bennett DA, Chen WG et al (2011) Improving the pharmacologic management of pain in older adults: identifying the research gaps and methods to address them. Pain Med 12:1336–1357
Rudolph JL, Salow MJ, Angelini MC, McGlinchey RE (2008) The anticholinergic risk scale and anticholinergic adverse effects in older persons. Arch Intern Med 168:508–513
Sidana A, Singh GP, Sharma RP (2002) Zolpidem induced delirium (letter to the editor). Indian J Psychiatr 44:398
Stockl KM, Le L, Zhang S, Harada AS (2010) Clinical and economic outcomes associated with potentially inappropriate prescribing in the elderly. Am J Manag Care 16(1):e1–e10
Toner LC, Tsambiras BM, Catalano G, Catalano MC, Cooper DS (2000) Central nervous system side effects associated with zolpidem treatment. Clin Neuropharmacol 23:54–58
Vestergaard P, Rejnmark L, Mosekilde L (2006) Anxiolytics, sedatives, antidepressants, neuroleptics and the risk of fracture. Osteoporos Int 17:807–816
Voyer P, Richard S, Doucet L, Carmichael PH (2009) Predisposing factors associated with delirium among demented long-term care residents. Clin Nurs Res 18:153–171
Wright RM, Roumani YF, Boudreau R et al (2009) Effect of central nervous system medication use on decline in cognition in community-dwelling older adults: findings from the Health, Aging and Body Composition Study. J Am Geriatr Soc 57:243–250
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer-Verlag Wien
About this chapter
Cite this chapter
Fick, D.M. (2013). Central Nervous System (CNS) Medications and Delirium. In: Wehling, M. (eds) Drug Therapy for the Elderly. Springer, Vienna. https://doi.org/10.1007/978-3-7091-0912-0_20
Download citation
DOI: https://doi.org/10.1007/978-3-7091-0912-0_20
Published:
Publisher Name: Springer, Vienna
Print ISBN: 978-3-7091-0911-3
Online ISBN: 978-3-7091-0912-0
eBook Packages: MedicineMedicine (R0)